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Abstract

Gastrointestinal parasites such as the nematode Haemonchus contortus and protozoa
Coccidia pose a serious threat to the global goat industry due to resistance of parasites to
anthelmintic drugs. The objective of this study was to evaluate the effect of extracts of CorPet
biomass, a mushroom (Coriolus versicolor) on gastrointestinal parasite infection and innate
immunity in goats. Fifteen female SpanishXBoer goats were drenched with 10 ml of either a hot
extract of CorPet (N=5), a cold extract (N=5), or with sterile water (control N=5) for eight
weeks. Treatment groups were reversed after four weeks. Body weight, body condition and
FAMACHA scores, fecal and blood samples were collected weekly. Blood was used for white
blood cell differential counts, packed cell volume and isolation of total RNA. Fecal samples
were used for microbial DNA isolation and enumeration of parasite eggs. The Nanodrop
spectrophotometer was used to determine the concentration and purity of DNA and RNA.
Neutrophils were isolated using differential centrifugation and hypotonic lysis of red cells from
blood. RNA was isolated from neutrophils using Trizol and then converted to cDNA. The human
Toll-like receptor signaling pathway array was used to profile the expression of 84 genes. Total
plasma protein concentration was determined using the BCA assay and migration patterns on
silver stained gels. Pro-inflammatory cytokine and Prostaglandin E2α secretion was determined
by ELISA. Data were analyzed using SAS statistical analysis software (P<0.05). Mushrooms did
not affect health indicators including fecal egg counts (p>0.05) and increased plasma proteins
(p<0.001). Treatment decreased GMCSF and increased GCSF, and IFNr, secretion. Treatment
modulated expression of goat neutrophil Toll-like receptor pathway genes. Eight TLR’s were
expressed on goat neutrophils. The highest fold change was observed for TLR6 and TIRAP.
Modulation of these genes using CV mushroom probiotics as an oral has implication for health.
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CHAPTER 1
Introduction
Growth in population is increasing thereby increasing the demand in food. By the year
2050, it is projected that the world population would be expected to reach 8.3 to 10.9 billion.
This population growth has led to the increased demand of food. The world goat population has
been on the increase during the last three decades and currently stands at almost 840 million
herds (Simela et al., 2008). They predominate as the major livestock in the poorest parts of the
world (Simela et al., 2008). To ensure that food does not become a privilege-commodity,
scientists are exploring new approaches with sustainable resources and innovations within these
essential agricultural sectors to accommodate for and stabilize supply in this era of a rising
population (Godfray et al., 2010).
Ruminant products contribute to one of the major sources of food and protein consumed
worldwide. Production of small ruminant is a growing industry in the U.S due to stable ethnic
markets (NASS, 2009), rapidly increasing demand for grass-fed, or organically produced
livestock (Green et al., 2003), and the growing popularity of specialty meat type goat breeds
(Joshi et al., 2011). Meat goats do not require much supplemental feed and complicated
infrastructure to allocate the animals (Coffey, 2002). According to the United States Department
of Agriculture and the National Agricultural Statistics Service, three million herds of goats were
accounted for in the United States in the 2010 sheep and goat report. The recent increase in goat
production also results from the rising demand by increase numbers of ethnic groups into the
U.S. who favor goat meat and goat products (Engle et al., 2000). This new trend has brought
about new opportunities to grow and sustain goat production in the U.S. (Nadarajah, 2010).
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Goat production, however, is negatively affected by several factors: respiratory diseases
such as pneumonia, pregnancy toxemia and feed toxicity, including infectious and parasitic
diseases. Goats are vulnerable to viral and bacterial diseases, such as foot and mouth disease, and
mastitis. Among the latter, gastrointestinal infection remains one of the main constraints to dairy
goat production (Rinaldi et al., 2007). Gastrointestinal nematodes or parasites (GIN) are an
important limiting factor in goat production systems globally, and especially in humid climates
(Terrill et al., 2007). There are many parasites that cause an array of health problems in sheep
and goat production, but none more significant than H. contortus and Coccidia Emiria spp
(Miller et al., 2006). Due to overuse and incorrect application of anthelmintics to control
parasitic infection, the results have been increases in anthelmintic resistance weakening many
drug programs to control infection (Miller, 2000). However, as the anthelmintic resistance of
parasites to available products is increasing the need for improvement on current procedures for
their control becomes a priority (Thamsborgh et al., 1999). Introduction of breeding schemes for
resistance (Mandonnet et al., 2001), improved farm management practices and employing the
FAMACHA© system (Zajac, 2002) are many of the alternate approaches used. Plant based
anthelmintics have also been explored for use in the elimination of GI nematodes.
One potential alternative for control of GI nematode infection is to take advantage of the
host’s immune response in selection programs to increase the level of resistance in the
population. The innate immune system is the primary responder to non-specific pathogens and is
governed by phagocytic dendritic cells and macrophages. The responsibilities of the innate
immune system include the ability to differentiate between self (host) and foreign pathogens
(Akira, 2006). For many years, probiotics have been known to confer health benefits and may
have the ability to modulate immune responses. This research evaluates the effect of oral
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administration of CorPet powder, a mushroom powder, of Coriolus versicolor on the immune
response on goat.
The findings of this study could possibly aid in the improvements of GI nematode control
by identifying the genes involved in the innate immune response in goats. This study could also
provide the knowledge of the effects of mushroom probiotics as an alternative for control of GI
nematodes in goats to help improve strengthen GI nematode management practices in the United
States meat goat industry as it continues to develop.
The objective of this study was to evaluate the effect of extracts of CorPet on
gastrointestinal parasite infection and innate immunity in goats.

3

5
4

CHAPTER 2

Literature Review
2.1 Goat Production
The world goat population has been on the increase during the last three decades and
currently stands at almost 840 million herds (Simela et al., 2008). Goats are a critical resource
for milk and meat in many parts of the world. They predominate as the major livestock in the
poorest parts of the world (Simela et al., 2008). Production of small ruminant is a growing
industry in the U.S due to stable ethnic markets (NASS, 2009), rapidly increasing demand for
grass-fed or organically produced livestock (Green et al., 2003), and the growing popularity of
specialty meat-type goat breeds (Joshi et al., 2011). Goat production is an important industry in
southeastern United States because of availability of forages and a rising market demand
particularly for organically produced meat (Robinson, 2004). It is an attractive enterprise for
farmers due to the relatively low cost of breeding stock, a high reproductive rate, requirement of
minimal capital input as compared to other livestock species, and the ability of small ruminants
to thrive on native pasture or brush land that is unsuitable for cropping or grazing by cattle
(Schiere et al., 2002). Meat goats do not require much supplemental feed and complicated
infrastructure to allocate the animals (Coffey, 2002) and their sturdiness and small size allows
them to adapt to different environments (Engle et al., 2000).
The recent rise in goat production and products in the U.S. can be directly attributed to
the effects of an expanding market aligned with the on-going increase in foreign-born ethnic
groups migrating to the U.S. with a preference for goat meat and products (Solaiman, 2007).
Additionally, goat meat is considered as lean meat and can be a beneficial meat-substitute for
people seeking healthier diet alternatives (Solaiman, 2007). Due to the increased number of
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consumers of goat products, growth in demand is projected to follow (Nadarajah, 2010).
Although this new facet of agriculture is growing, it faces many challenges due to the lack of
organization and structure in the goat market (Nadarajah, 2010). This growth still brings many
opportunities to improve and sustain the goat market as the demand for goat meat and other
byproducts increase. Improving selective genetic schemes and nutrition within marketed goat
breeds will be an important factor to the growth and future of the United States goat industry, as
structure is gained (Nadarajah, 2010).
2.1.1 Parasite Problem in Goat Production. Goats are a critical resource for milk and meat
in many parts of the world, but are still susceptible to a number of diseases. Among the conditions
affecting goats are internal parasites, respiratory diseases such as pneumonia, foot rot, pregnancy
toxemia and feed toxicity. Goats are also susceptible to various viral and bacterial diseases, such
as foot and mouth disease, pink eye, and mastitis. Parasitic infection is recognized worldwide as
a limiting factor in the production of goats. Infection with internal parasites and gastrointestinal
nematodes is a major threat to the health and productivity of small ruminants (sheep and goats)
in the United States, particularly in recently-weaned kids and lambs (Bowan, 2009).
Gastrointestinal (GI) nematode infections are common in grazing ruminants worldwide
and still are one of the main constraints to ruminant production because they can depress food
intake, tissue damage, reduction in skeletal growth and live-weight gain (Waller, 1997).
Economic losses caused by GI nematodes are associated with decreased production and limited
performance (Abebe et al., 2000). Combining knowledge of GI nematodes epizoology with
modern anthelmintics has allowed great success on parasite control over the past decades.
However, as the anthelmintic resistance of parasites to available products is increasing the need
for improvement on current procedures for their control becomes a priority (Thamsborgh et al.,
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1999). The need for controlling GI nematodes is of great importance in small ruminant
production.
Coccidiosis is a disease caused by a protozoa Eimeria spp which naturally occurs in soils
is a major concern in young animals whose immune system has not matured (Kommuru et al.,
2014). The coccidia that are more pathogenic in goats are E. arloingi, E. christenseni, and E.
ovinoidalis (Kahn et al., 2010). During weaning, goats encounter lowered immune function
creating favorable conditions for an outbreak of coccidiosis that can rapidly spread in a herd of
flock causing devastating consequences of diarrhea, dehydration, and even death (Bowan, 2009).
The parasite causes harm to the host by destroying the mucosal lining of the abomasum depleting
nutrient up-take, and leading to liver failure in dairy goats (Khan et al., 2010). Coccidiosis is of
great economic importance because of the losses due to clinical disease (diarrhea) and
subclinical infections, as well as poor weight gain in particular (Chartier et al., 2011).
In the United States and other countries around the world, Haemonchus contortus also
known as the barber pole warm is the most important parasite from the strongylid nematodes. H.
contortus is one of the most prolific nematodes. According to Mortensen et al., 2003, H.
contortus account for 75-100% of the total fecal nematode egg output which is a blood sucking
parasite that thrives in warm climates. Female H. contortus reach about three cm in length,
making this species one of the largest of the strongylid nematodes of ruminants (Elsheikha et al.,
2011). A female worm may produce thousands of eggs each day and larvae on pastures can
accumulate rapidly during the grazing season in regions where this species predominates. The
prepatent period (length of time elapsing between infection of the host and parasite maturity)
of H. contortus is about 17 to 21 days (Levine, 1985). Adult worms are short lived surviving in
the host for only a few months (Courtney et al., 1983). H. contortus has great pathogenic
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potential because fourth-stage larvae and adults feed on host blood. Consequently, its effects on a
flock or herd are often insidious because routine observation of animals may not reveal the
extent of infection and owners may not recognize that disease is present until deaths occur. With
favorable conditions for the survival and growth of the ‘free-living’ stages of H. contortus,
during the warmer months of the year throughout much of the southern and eastern United States
(warm and moist) kids and lambs grazing with their mothers can acquire a significant GI
nematode infection which then increase at weaning due to increase exposure to the infective third
stage (L3) larvae and stress (Kommuru et al., 2014). The fourth and final stage (L4) of the H.
contortus life cycle is the reproduction stage. After the larvae penetrate the abomasum (true
stomach) there is molting for a fourth and a fifth time to transition into the adult phase. Males
and females feeds off of the host blood in the abomasum and reproduce with the female laying
5,000 to 10,000 eggs per day passing through the feces to the external environment (Zajac,
2006). The total process of the H. contortus life cycle, from the L1 to the L4 stage, takes roughly
three weeks (Luginbuhl, 2000).
2.1.2 Life Cycle of Haemonchus contortus. The life cycle of parasites starts with adult
females laying eggs while residing in the abomasum. The eggs when laid are oval in shape and
pass out of the animal in feces. At 260C and 100% humidity, the eggs take fourteen to seventeen
hours to hatch and develop into L1 larvae stage. L1 larvae develop on pasture into L2, L3 and
following ingestion by ruminant host, into the L4 stages before reaching the adult stage. After
copulation, the adult females start laying eggs eighteen days after an oral infection with L3 and
can be fully gravid by day 33. The L3 is the infective larval stage in which the host inadvertently
ingests the parasite and it develops into an adult in the abomasum where they feed on blood
(Nikolaou, 2006).
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2.2 Innate Immune System
Goat production is negatively affected by several factors including infectious and
parasitic diseases. Among the latter GI infection remains one of the main constraints to goat
production (Rinaldi et al., 2007).
The main function of the immune system is to distinguish its own cells and tissues from
other external cells and tissues in order to protect against infestation. The immune system has
various mechanisms to eliminate external agents which include inactivation, lysis, agglutination,
precipitation, or phagocytosis of foreign cells (Kahn et al., 2010). The animal immune system is
composed of two related functional elements: the innate immune system and the adaptive
immune systems (Hoffmann et al., 1999). Both function in coordination to protect against
invading microorganisms (Medzhitov et al., 2002).
Innate immunity is the first line of defense against organisms; it acts in a non-specific
way through anatomical barriers (skin, mucus membrane), secretions and other elements. The
adaptive immune system is the second line of defense which responds slower than the innate
immunity system. Innate immune defense plays a key role in affording protection (Siwicki et al.,
1994). Unlike the innate immune system, the adaptive immune system has the ability to
“memorize” infectious agents allowing the adaptive immune system to serve as a rapid response
system if pathological agents are encountered again (Medzhitov et al., 2002). The innate immune
system consists of natural killer cells, T-cell and B-cell, basophils eosinophils, monocytes,
macrophages and polymorphonuclear neutrophils. These cells are called white blood cells or
leukocytes and are also divided into two groups based on their morphology, granulocytes and
agranulocytes. Granulocytes include eosinophils, neutrophils and basophils and agranulocytes
are lymphocytes (T and B cells) and macrophages (Kaplan et al., 2004).
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A differential white blood cell count is an important tool used to provide clinical
diagnosis, monitoring of disease and blood disorders (Houwen, 2001). This system quantifies
and differentiates white blood cells at one particular time giving insight to infection and if
treatments are working (Houwen, 2001). White blood cell differentiation counts can be
accomplished manually or by automated electronic systems (Krapp et al., 2002). The white blood
cell percentages are determined by the counting of the ratio and morphology differentiation of
the first 100 white blood cells observed (Khan et al., 2010).
Table 1.
White Blood Cell Differential Count Normal Value for Goats in Percentage (%). Adapted from
Khan and Line, 2010
Neutrophils

Lymphocytes

Basophils

Monocytes

Eosinophils

30-48

50-70

0-1

0-8

1-8

2.3 Diagnosis of Gastrointestinal Parasites
The most common symptoms of goats experiencing parasitic burden depends heavily on
the observation of clinical symptoms associated with parasitic infection especially with H.
contortus and Coccidia. The major limitation is instituting a selective approach which identifies
those animals requiring treatment. Anemia is the most detrimental effect of H. contortus
infection which leads to death. The most common symptoms include high fecal egg count (FEC),
weight loss and diarrhea. Phenotypic criteria can be used to indirectly estimate resistance to
parasites such as fecal egg counts, white blood cell differential count, FAMACHA, packed-cell
volume or immunological traits (Dominik, 2005). The McMaster egg counting technique is used
to determine the levels of parasitic burden. Goats infected with H. contortus with a FEC greater
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than 1000 epg indicate heavy infection while 500 epg signifies mild infection (Taylor, 2010).
Oocyte counts of 5000 per gram or more in feces of host suspected of coccidia infection is
indicative of clinical infection (Schoenian, 2011). It is also very important to evaluate hematocrit
levels periodically to diagnose parasitic infection (Miller, 2000). This method is effective in
assessing anemia probably caused by parasitism in sheep and goats (Khan et al., 2010).
The use of the FAMACHA© card system is a system that was developed in South Africa
for the classification of animals into categories based on levels of anemia caused by
gastrointestinal parasites (Reynecke et al., 2011). In this method, called FAMACHA©, the ocular
mucous membranes of sheep and goats are classified by comparison with a laminated color chart
bearing pictures of sheep conjunctivae classified into five categories ranging from the normal
red, through pink to practically white in severe anemia. Since anemia is the primary pathologic
effect from infection with H. contortus, this system can be an effective tool for identifying those
animals that require treatment (Kaplan, 2004). The FAMACHA system is widely used and is
accepted by sheep and goat producers in the southern U.S. (Burke et. al., 2007).

Figure 1. FAMACHA Anemia Guide (Kaplan et al., 2004).
2.4 Treatment
One potential alternative for control of GI nematode infection is to take advantage of the
host’s immune response in selection programs to increase the level of resistance in the
population. Resilience is the ability to be productive despite infection. The traditional treatment
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for infection with GI nematodes in weaned animals is the use of anthelimintics. Control of GI
infections in goats relies almost exclusively on multiple and regular dosing of anthelmintics
(Rinaldi and Cringoli, 2012). All of the approved available anthelmintics for goats in the United
States fall into one of three major drug groups: the benzimidazoles, the cholinergic agonists, and
the macrocyclic lactones (Zajac, 2006). Only Decoquinate and Monensis are FDA approved for
the prevention of coccidiosis, but no drugs are approved for treatment of coccidiosis in goats
(Kommuru, 2014). Anthelmintics therefore are needed but current ones are ineffective due to
anthelmintics resistance especially in the humid tropics, where the free-living stages of parasitic
nematodes such as H. contortus (Kaplan, 2004) meet adequate climatic conditions to develop
during almost the entire year (Mahieu et al., 2007).
Since the advent in the 1960s of modern broad-spectrum anthelmintics with wide safety
margins, producers have relied on dewormers for control of GI nematodes in the United States.
In the southeastern United States where H. contortus causes substantial losses, frequent
treatments were used (and recommended to producers) throughout the grazing season in
suppressive anthelmintic programs that kept egg production and pasture contamination at low
levels (Kaplan 2004). For most producers, parasite control continues to include treatments with
anthelmintic drugs, but any veterinarian working with small ruminant producers must stress the
importance of alternative methods of parasite control that can be used in combination with
anthelmintics (Zajac, 2006).
Due to growing levels of resistance in these gastrointestinal nematodes to current drugs
and the lack of interest in developing new drugs by companies, small ruminant producers are
desperate for solutions (Zajac, 2002). Drug resistance by nematodes has resulted in the search for
better treatment methods including the use of non-chemical alternatives. They include production
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practices and the use of genetics based breeding schemes to contend with anthelmintic resistance
of GI nematodes.
Plant based anthelmintic have also been explored for use in the elimination of GI
nematodes with such extracts like: Garlic (Allium sativum) (Worku et al., 2009), neem
(Azadirachta india), wormwood (Artemisia absinthium), and tobacco (Nictiana tobacum)
(Worku et al., 2009). Other measures which have been used include reduction of stock density
and the maximization of pasture to reduce parasite numbers as alternative management practices.
Placing animals on a high nutritional plan was described by Zajac (2002), to aid in the
development of an immune response allowing goats to develop some natural immunity against
the parasites before using anthelmintics as a best management practice. Finally, substances able
to modulate immune functions are also being incorporated in animal feed to stimulate host
defense (Gallois et al., 2008, Hoste et al., 2008). Improvement in animal nutrition can also
impact the immune response including gene response, protein synthesis, modification and
degradation, metabolism, signal transduction and cellular proliferation (Afacan et al., 2012).
The understanding of protective mechanisms regarding the initial steps of the host’s
response to pest or parasite derived molecules that can correlate with resistance or susceptibility
to pathogens needs to be explored for economically important pests of ruminants. This
understanding will aid the design of immune-modulatory strategies to induce a change in the
magnitude of immune or non-immune responses.
2.5 Mushroom
The term mushroom can be defined as ‘a macro fungus with a distinctive fruiting body,
large enough to be seen with the naked eye and to be picked by hand’(Chang, 1999). The number
of species mushrooms on earth is estimated at 140,000, yet maybe only 10% (approximately
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14,000 named species) are known (Wasser 2002), of which only about 650 species are reported
to be of medicinal value (Minato, 2010). Mushrooms have been appreciated and consumed for
their nutritional value and medicinal properties in several countries over the years and have been
used not only as a source of food but medicinal resource as well (Wasser, 2002). Researchers
have considered mushrooms as healthy food because they are good sources of vitamins,
minerals, proteins, and carbohydrates apart from the low level of lipids and low caloric content
(Wasser, 2002 and Kalac, 2009). Mushroom extracts have been reported to exhibit antioxidant
properties (Tsai et al., 2009), which makes them excellent sources of β-glucans and are rich in
many bioactive metabolites of high medicinal value such as lectins, polysaccharides, phenolic
and polyphenolics, terpenoids and volatile organic compounds (Kalac. 2013). The low total fat
content and high proportion of polyunsaturated fatty acids relative to the total fatty acids of
mushrooms are considered significant contributors to the health value of mushrooms (Sanodiya
et al., 2009). Mushroom extracts have been shown to exhibit immumomodulator,
antitumor/anticancer, antibacterial and antiviral, antioxidant, and antihypoglycemic activities.
Therefore, there has been an urge to use mushrooms as an alternative method to promote animal
health.
2.5.1 Coriolus versicolor. Coriolus versicolor (CV) formerly known as Trametes
versicolor is pore-bearing basidiomycetes. Its fan-shaped fruiting bodies grow in overlapping
clusters on dead logs (Fig. 2). The top of it is zoned, usually in shades of brown, white, gray, and
blue bands while the underside is white and bears minute pores (Hobbs, 2004). This edible
mushroom is widely distributed all over the world in temperate zones of Asia, Europe and North
America and may be the most common shelf fungus in the Northern Hemisphere (Cui et al.,
2003).
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Figure 2. C. versicolor mushroom (fruiting body) growing on tree trunk (Courtesy of Frank L.
Hoffman).
2.5.2 Morphology. The morphological characteristics of CV fruiting body have been
described (Cui et al., 2003) as follows: 3–5 cm across brackets that are semicircular, flattened,
thin, and tough. Young brackets are flexible and usually occur in tiers and spread along branches.
The upper surface is velvety and attractively marked with concentric zones of varying colors:
brown, yellow, gray, greenish, or black. The margin is usually wavy. The mushroom has white
spores that are oblong and cylindrical. In agitated submerged culture, the fruiting body and
spores do not form, and the fungus grows as dispersed or pelleted mycelium. More than 120
strains of CV have been recorded.
The therapeutic potential of CV is gaining acceptance among patients worldwide (Lau et
al., 2004). The active ingredients in CV are polysaccharides, in particular polysaccharide krestin
(PSK, a protein-bound polysaccharide) and polysaccharide-peptide (PSP) (Chan and Yeung,
2006). They exert their therapeutic effects by modulating the host’s immune response. Both
preclinical and clinical evidences have demonstrated that extracts from CV display a wide array
of biological activities, including stimulatory effects on the immune system and inhibition of
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cancer growth (Zhou et al., 2007). The aqueous extract of CV was found to be effective in
activating T lymphocytes, B lymphocytes, macrophages, natural killer (NK) cells, and
lymphocyte-activated killer cells (Ng, 1998), as well as promoting the production of antibodies
and various cytokines, such as IL-2 and IL-6, and tumor necrotic factor (TNF) in vivo (Yang et
al., 1999). Oral administration of PSP to normal mice resulted in an elevated production of
cytokines that can stimulate the proliferation of T cells and activation to cytotoxic T cells
(Rowan et al., 2003). CV polysaccharopeptides can remedy intestinal disorders and are beneficial
in the therapy of opportunistic microbial infections that suppress the immune response (Cui et
al., 2003).
Studies have demonstrated that dietary immunomodulators such as β-glucan show
beneficial results in a wide variety of animal species (Hahn et al., 2006). The immunostimulant
and immunomodulatory effects of β-glucan polysaccharides result in the regeneration of the
host’s ability to fight infections (Rieder et al., 2013). The immunomodulatory process initiates
when the β-glucan binds to cell surface receptors of macrophages, lymphocytes and neutrophils
(Chen et al., 2007). β-glucan activates B-lymphocytes and macrophages through toll-like
receptors, modulating the immune system and inducing the production of cytokines (Liao et al.,
2004). These cytokines in turn activate adaptive immunity through the production of B cells for
antibody production and stimulation of T cell differentiation to T helper (Th) 1 and Th2 cells,
which mediate cell and humoral immunities, respectively (Bochers et al., 2008). It was also
demonstrated that β-glucan may enhance the innate immune responses, including lymphocytes
proliferation and antibody production (Gopalalakannan et al., 2010). An opportunity exist to
understand the harness therapeutic potential of the use of mushroom extracts in animal health
and production to ensure food security and meet the protein needs of the expanding world
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population. Mushrooms seem to be a potential candidate for prebiotics as it contains
carbohydrates like chitin, hemicellulose, β- and α-glucans, mannans, xylans and galactans.
Prebiotics can be defined as selectively fermented ingredients that allow specific changes, both
in the composition and/or activity in the gastrointestinal microbiota that confers benefits upon
host well-being and health (Gibson et al., 2004).
2.5.3 Mushrooms in Animal Health. The health benefits using mushrooms or their
extracts in animals have been extensively reported. CV is considered as a strong potential
candidate for drug development in treatment and suppression of DNA and RNA synthesis and
enhances immune functions (Hsiehet al., 2002). Mushrooms and mushroom components have
been reported to have a myriad of positive health benefits, mainly on the basis of in vitro and in
vivo animal trials (Roupas et al., 2012). Mushrooms and mushroom components exert many of
their positive effects on health via a balance of T helper cells, the induction of interferon-gamma
and certain interleukins or NO-mediated mechanisms. Many of these immunomodulating effects
are due to the polysaccharide content of mushrooms, either from β-glucan or from
polysaccharide–protein complexes (Roupas et al., 2012).
2.5.4 Mechanism of Action. The best-known effect of β-glucan consists of the
augmentation of phagocytosis of granulocytes, monocytes, macrophages and dendritic cells. In
this regard, macrophages considered being the basic effector cells in host defense against
bacteria, viruses, parasites and tumor cells, play the most important role (Vetvicka et al., 1996).
This innate immunity is based on non-clonal receptors (pattern recognition receptors, PRRs),
which recognize certain molecules on the surface of invading microorganisms and are
collectively termed as pathogen-associated molecular patterns (PAMPs). The first step of βglucan -macrophage interaction is binding to specific receptors (PRRs) present on a surface of
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the macrophage cell. For β-glucan recognition, the macrophages keep several receptors at their
disposal: TLR-2 (Toll-like receptor 2), dectin-1, CR3 (complement receptor 3), lactosylceramide
and probably others. However, the interaction between β-glucan and CR3 receptor is established
more effectively than at the other receptors. Binding to PRRs, such as toll-like receptor-4
(TLR4), dectin-1 and complement receptor 3 (CR3) by polysaccharides can activate immune
responses by enhancing the secretion of TNF-alpha, IL-6 and other inflammatory cytokines.
Pathogen recognition receptors also serve to bind ligands that prime immune responses (Ofodile,
2007). While there has been considerable research on how isolated β-glucan activates cytokine
production through dectin-1 and CR3, there are few reports on the mechanisms of how
traditionally used medicinal mushroom preparations that contain polysaccharides, interact with
PRR (Price et al., 2010). However, there are no published reports on the effects of Coriolus
versicolor mushroom extracts on PRR pathways. No work has been done on goats.
2.6 Toll-like Receptors
Animals live in a wide variety of microbe-rich environments and hence it is crucial to
have a sensitive innate defense mechanism which relies in part by recognizing conserved
molecules that are unique to some classes of potential pathogens (Tirumurugaan et al., 2010). It
is very important to understand the innate immunity against microbial components and its critical
role in host defense against infection. Toll-like receptors (TLRs) are a highly conserved group of
proteins that have been identified in mammals (Medzhitov et al., 1997). Following the discovery
of Toll-like receptors (TLRs) in the mid-1990s it has been clearly shown that pathogen
recognition by the innate immune system is broadly specific, relying on germline-encoded
pattern-recognition receptors (PRRs) that have evolved to detect relatively conserved
components of pathogens referred to as pathogen associated molecular patterns (PAMPs)
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(Janeway et al., 2002). The PAMPs recognized by TLRs include lipids, lipoproteins, proteins and
nucleic acids derived from a wide range of microbes such as bacteria, viruses, parasites and fungi
(Akira et al., 2006) which initiates a complex signaling cascade to activate a wide variety of
transcription factors and inflammatory cytokines (Takeda et al., 2005).
The TLR family consists of ten receptors: TLR-1 through TLR-10, which are very
important in the identification of microbes (Takeda et al., 2005). The coding regions within the
sheep and goats TLR 1-10 genes have been sequenced and found to be conserved and highly
similar in nucleotide composition (Raja et al., 2011). Tirumurugaan et al. (2010), used bovine
specific primers to amplify goat TLR mRNA. Toll-like receptor 4 (TLR-4) recognizes
lipopolysaccharide, which is associated with the protein in gram-positive bacteria membranes
and is bound; pathogen recognition activates the innate immune response (Akira et al., 2004).
Effect of toll-like receptors has not been studied.
2.7 Cytokines
The nature of an immune response is greatly influenced by the pattern of cytokines
secreted during that response. Cytokines are small proteins that transmit information from one
cell to another. The analysis of cytokines secreted by immune cells in response to infectious
agents is crucial to understand pathogenesis and immunity. Most cells in the body produce
cytokines during inflammatory processes which represent a large series of regulatory proteins of
the immunologic system. Many cytokines are referred to as interleukins, a name indicating that
they are secreted by some leukocytes and act upon other leukocytes. Two general patterns of
cytokine secretion by such cells have been described: In the Th1 response cytokines initiate cell
mediated reactions defined as the activation of macrophages to combat infectious pathogens by
releasing IL-1, IL-2, IL-8, and IL-12 to activate inflammation (Raghupathy, 2001). In the Th2
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response, T-helper cells activate B-cells; interleukins IL-4, IL-5, IL-6, IL-10 and IL-13 are
released to counter infectious agents caused by extracellular organisms (Raghupathy, 2001).
5
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CHAPTER 3

Materials and Methods

3.1 Animals
Fifteen female SpanishXBoer goats were selected from the herd at North Carolina
Agricultural and Technical University (NCA&TSU) Small Ruminant Research Unit. All animals
were ear tagged prior to the study. Animals were clinically healthy and not under any treatment
prior to the study. It was approved by Institutional Animal Care and Use Committee (IACUC).
Initial screening was carried out to determine body weight, body condition, packed cell volume
and the level of coccidian oocyst and H. Conturtus egg in fecal sample.
3.2 Experimental Design
A complete randomized design was used in assigning treatment to each before screening.
A two period crossover design was conducted (Park et al., 2010) to analyze all variables.
3.3 Housing
During the experiment the goats were housed in a barn with wood shavings at night and
pasture during the day. Water and feed supply were provided ad libitum. The barn had good
sanitation and good management.
3.4 Feeding
The animals were supplemented under balanced diet feed (Southern States Quality kid
and Goat Feed) which contained a high-protein, high-energy mixture fortified with vitamins and
minerals such as ammonium chloride, copper and zinc. The goats were fed two pounds of feed
per animal once a day. Also the animals were fed with hay ad libitum.
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3.5 Preparation of Mushroom Extracts
CorPet powder (Coriolus versicolor) was purchased from Mycology Research Labs Ltd
(United Kingdom). Twenty-five (25) grams of CorPet was weighed out and stirred in 250 ml of
sterile endotoxin free distilled water. Protein content for the mushroom extract was determined
using the PierceTM Bicinchoninic Acid (BCA) Assay kit (Rockford, IL) to determine the level of
protein to be administered to the animals.
3.5.1 Extract Preparation. Heated extracts was prepared by first weighing 25 g of
CorPet powder in 250 ml of distilled water and heated with stirring for 20 minutes. The extracts
were left to cool and then stored at 40C. Cold extracts were prepared by weighing 25 g of CorPet
powder in 250 ml of distilled water and stirred for 20 minutes and stored in 40C.
3.5.2 Drench Administration. Ten (10) ml of the extract was given to each goat on daily
basis for 60 days. Ten (10) ml of distilled water was also given to the control group daily for 60
days. Treatments were reversed after the first 30 days in a crossover design.
3.6 Sample Collection
All samples were collected and evaluated once a week throughout the experiment.
3.6.1 Body weight. Goats were weighed on a portable scale in Kg before they were fed in
the morning.
3.6.2 Body condition Scores. Body condition was determined by physically assessing
the rib areas using firm pressure with the fingers and running fingers down the goat’s spine from
the shoulders to the tail head, and degree of fat cushion over these bones determines the score.
Body condition refers to the fleshiness of the goat which is scored from 1 to 5, where 1 is very
lean, 2 is lean, 3 is moderately good condition, 4 is fat, and 5 is obese (Mendizabel et al., 2010).
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3.6.3 FAMACHA Eye Color Score. The FAMACHA chart is a parasite monitoring
system used to correlate fecal egg count (parasitic load) with color of the ocular conjunctiva
(Kaplan et al., 2004). Using this method, animals were classified into 5 categories according to
eye mucus color; category number 1 = red, non-anemic; 2= red-pink, non-anemic; 3 = pink,
mildly anemic; 4 =pink-white, anemic; 5 = white, severely anemic.
3.6.4 Collection of Fecal Samples. Fecal samples were collected by applying lubricant
and inserting the index middle finger directly into the rectum wearing sterile gloves for each
animal. Collected samples were placed in labeled clean zip-lock plastic bags to determine fecal
egg count.
3.7 Fecal Egg Count
A modified McMaster technique was used for fecal egg count as described by Whitlock
(Kaplan et al., 2004). Two (2) grams of feces were weighed and dissolved in 28 ml of saturated
sodium chloride to cause parasites eggs to float to the top of the liquid. Pellets were broken down
using a spatula. Ten (10) ml syringe was used to transfer aliquots of the solution into both
McMaster slide chambers and examined under an Olympus B X40 microscope using 10X
magnification according to the Paracount-EPGTM Fecal Analysis Kit (Chalex Corporation,
Wallowa, OR). The number of coccidia oocyst and H. Conturtus egg were counted in duplicate,
the average was calculated, and then multiplied by 50 to get the eggs per gram (epg) of feces for
each animal (Kaplan et al., 2004).
3.8 Isolation of Microbial DNA from Fecal Samples
The QIAamp (R) DNA isolation stool mini kit (50) (QIAGEN Sciences, Maryland) was
used to isolate DNA from fecal samples as recommended by the manufacturer. Briefly 200 mg of
fecal samples from each goat was weighed and transferred into a clean tube and placed on ice.
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Two (2) ml of lysis buffer (ASL) buffer was then added to each tube. Tubes were vortexed
continuously for I minute until the stool sample was thoroughly homogenized. The stool lysate
of 1.6 ml was pipette into a labeled 2ml micro centrifuge tube. The suspension was heated for 5
minutes at 700C. The tubes were vortexed for 15 seconds and centrifuged at full speed for 1
minute to pellet stool particles. The supernantant (1.2ml) was pipetted into a new 2 ml micro
centrifuge tube. One inhibitEX tablet was added to each sample and vortexed immediately and
continuously for 1 minute at room temperature to allow inhibitors to adsorb to the inhibitEX
matrix. Samples were then centrifuged at full speed for 3 minutes to pellet stool particles and
inhibitors bound to inhibitEX matrix. The supernatant was pipetted into a new 1.5 ml micro
centrifuge tube and the pellet was discarded.
The sample was centrifuged at full speed for 3 minutes. The supernatant (200 µl) was
transferred into a 1.5 ml micro centrifuge tube containing 15 µl of proteinase K. AL buffer (200
µl ) was added to each tube and vortexed for 15 seconds. Tubes were then incubated for 10
minutes at 700C. Ethanol (200 µl) (96%) was added to the lysate and mixed by vortexing. The lid
of a new QIAamp spin column was labeled and placed in a 2 ml collection tube. The complete
lysate was carefully transferred to the QIAamp spin column without moistening the rim. The cap
was properly closed and centrifuged at full speed for 1 minute. The QIAamp spin column was
placed in a new 2 ml collection tube, and the tube containing the filtrate was discarded. The
QIAamp spin column was carefully opened and 500 µl of buffer AW1 was added. The cap was
closed and centrifuged at full speed for 1 minute. The QIAamp spin column was placed in a new
2 ml collection tube and the collection tube containing the filtrate was discarded. Wash buffer
AW2 (500 µl) was added and centrifuged at full speed for 3 minutes. The collection tube
containing the filtrate was discarded. The QIAamp spin column was transferred to a new 2 ml
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collection tube and centrifuged at full speed for 1 minute. The old collection tube with the filtrate
was discarded. The QIAamp spin column was transferred into a new-labeled 1.5 ml
microcentrifuge tube and then 200 µl of buffer AE was then pipetted directly onto the QIAamp
membrane. The cap was closed and incubated at RT for 1 minute, and then centrifuged at full
speed for 1 minute to elute DNA. The concentration (260 nm) and quality or purity (260/280 nm)
of the isolated DNA samples were determined using the Nanodrop Spectrophotometer 1000 3.7.1
(Thermo Scientific Inc., MA).
3.9 Blood collection
Blood samples (15 ml) were collected from the junglar vein into 2.5 ml PAXgene blood
RNA tubes (QIAGEN Inc, Valencia,CA) for extraction of RNA. The PAXgene tube contains a
reagent that immediately stabilizes intracellular RNA for 3 days at room temperature (18-250C)
and 5 days at 2-80C. Blood ten (10) ml was also collected into vacutainer tubes containing 0.9ml
of Acid Citrate Dextrose for isolation of neutrophils. Blood was also used to determine packed
cell volume and blood smears were prepared for total white blood cell differential counts.
3.10 Laboratory Analysis
3.10.1 Packed Cell Volume. Heaprinzed hematocrit micro-Capillary tubes (Drummond
cat # 1-000-7500-HC/5) were used to collect blood in duplicate from tubes containing
Ethylenediaminetetraacetic (BD, Franklin Lakes, NJ). Mico-capillary tubes were sealed with
clay sealant (Fisher Scientific Inc. Pittsburg, PA) and placed in numbered duplicate sample slots
and then centrifuged for 5 minutes at 14,000 rpm in an IEC MB Micro Hematocrit centrifuge
(Damon/IEC Division, Needham, MA). The capillary tubes were then placed in micro capillary
reader (BD, Franklin Lakes, NJ) to determine the PCV.
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3.10.2 Differential White Blood Cell Count. A thin blood smear was prepared in
duplicate by placing a drop of blood (approximately 4 mm in diameter) on one end of a micro
slide. A spreader slide was used at 450 angle to disperse the blood over the slides length in order
to space out cells far enough to be counted and differentiated. The slide was left to air dry at
room temperature then stained with Sure Stain Wright CS-432 solution according to the
manufacturer’s instructions (Fisher Scientific Inc. Pittsburgh, PA). The slides were dipped in
Wright stain for 10 seconds then in deionized water for 15 seconds, and finally rinsed by dipping
in fresh deionized water for 10 seconds. The slides were left to dry at room temperature. White
blood cell differential counts were carried out by placing slides under 100X magnification of
Olympus B X40 microscope using mineral oil (Sigma-Aldrich St Louis, MO). Counting was
performed using Fisher Five Button Lab Counter (Fisher Scientific Inc. Pittsburgh, PA). Slides
were counted in duplicate to identify the percentage of lymphocytes, neutrophils, monocytes,
eosinophils, and basophils.
3.11 Plasma Preparation
Whole blood in a 15 ml tube containing anticoagulant citrate dextrose (ACD) was
centrifuged at 3600 rpm for 20 minutes to separate plasma from blood cells. Plasma, which was
at the top surface, was collected using a pipette into a 10 ml tube and stored at -700C.
3.11.1 Bicinchoninic Acid Assay (BCA). PierceTM BCA Assay kit (Rockford, IL) was
used to determine the total protein concentration content from plasma isolated from whole blood.
Protein standards were prepared (Appendix A).
Briefly 25 µl of each standard and unknown sample was pipetted into a 96-microplate
well (Thermo ScientificTM PierceTM, Rockford, IL). Working reagent (WR) was prepared by
mixing 50 parts of BCA reagent A with 1 part of BCA reagent B. Two hundred (200) µl of the
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WR was added to each well and mixed thoroughly on a plate shaker for 30 seconds. The plate
was then covered and incubated at 370C for 30 minutes. Plates were cooled to room temperature
(RT). A standard curve was created using the protein standard samples at 0µm/ml, 25µm/ml,
125µm/ml, 250µm/ml, 500µm/ml, 750µm/ml, 1000µm/ml, 1500µm/ml and 2000µm/ml and the
absorbance was measured at 562nm on a plate reader (BioTek Instruments Inc, Winooski VT).
Unknown sample concentrations were quantified by interpolating the optical density from the
standard curve and also the line of best fit.
3.11.2 Evaluation of the Secretion of Cytokines
3.11.2.1 Preparation of Protein standards. The human inflammation ELISA strip protein
standards (Signosis Inc, Santa Clara, CA) was used to profile selected cytokines. Two hundred
(200) µl of the diluent buffer was added to the well of the first strip of a 96 well plate, and then
100 µl of diluent buffer was added to the remaining wells of the strips according (See Appendix
C). Protein standards were added to the first strip. A multi-channel pipette was used to mix the
dilutions and transfer 100 µl to the next dilution wells. This transfer was done until the 5th strip.
No transfer was done to the 6th strip.
3.11.2.2 Cytokines. The Human Inflammation ELISA kit (Signosis Inc, Santa Clara, CA)
was used to determine pro-inflammatory cytokine amounts of eight cytokines: Tumor necrosis
factor-alpha (TNF-α), interferon regulator (IFNr), granulocyte-colony stimulating factor (GCSF), granulocyte macrophage-colony stimulating factor (GM-CSF), interleukin-1a (IL-1a),
interleukin-8 (IL-8), interferon inducible protein 10 (IP-10), and regulated on activation, normal
T expressed and secreted (RANTES) in pooled blood plasma. The assay was done in triplicate
according to the given protocol.
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Briefly according to the manufacturer, seals of the 96 well plates were properly removed
and then 100 µl of standard, control and treatment plasma samples were added into each well in
triplicate and incubated for 1 hour at room temperature with gentle shaking. Following
incubation each well was aspirated and washed by adding 200 µl of 1X wash buffer. This
process was repeated three times for a total of three washes. The plate was inverted onto a towel
after the final wash to ensure the removal of excess liquid. One hundred (100) µl of diluted
biotin-labeled antibody mixture was added to each well and incubated for 1 hour with gentle
shaking. Each well was aspirated and washed by adding 200 µl of 1X wash buffer. This process
is repeated three times for a total of three washes. The plate was inverted onto a towel after the
final wash to ensure the removal of excess liquid. Afterwards, 100 µl of diluted streptavidinHRP conjugate was added to each well and incubated for 45 minutes at room temperature with
gentle shaking. Each well was aspirated as before and washed by adding 200 µl of 1X wash
buffer. This process was repeated three times for a total of three washes. The plate was inverted
onto a towel after the final wash to ensure the removal of excess liquid. A 100 µl of substrate
solution was added to each well and incubated for 25 minutes at room temperature, followed by
the addition of 50 µl of stop solution into each well. There was a color change from blue to
yellow. The optical density was read at an absorbance of 450 nm using a micro plate reader
(BioTek Instruments Inc, Winooski VT). A standard curve was generated to identify optical
density of unknown samples. Unknown sample concentrations were quantified by interpolating
the optical density from the standard curve and also the line of best fit.
3.12 Sample Preparation
The plasma protein sample was mixed with an equal volume of 2X treatment buffer
(Laemmli, 1970) and boiled for 2 minutes to denature the proteins.
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3.12.1 Sodium Dodecyl Sulphate Poly Acrylamide Gel Electrophoresis (SDS-PAGE).
A discontinuous SDS-PAGE was done using 0.75-mm thick slab gels with a 4.5% stacking gel
and 12 % separating gel. Monomer gel solution was poured into glass gel cassettes. Deionized
water was added slowly over the monomer solution to ensure that the top of the gel was even.
After 30 minutes, the water was discarded and running gel overlay was added on the gel. The
gels polymerized overnight at room temperature. The gel overlay was then decanted. A 4.5%
stacking gel solution was prepared and pipetted onto the 12 % separating gel and a comb was
inserted into the stacking gel. The stacking gel was allowed to polymerize for 30 minutes. The
comb was removed after polymerization was complete. The samples were carefully loaded in the
appropriate wells. Electrophoresis was carried out with a current of 100 watts for approximately
1 to 2 hours using the LKB Slab Gel System and the Ephortec® 1000 volt power supply unit.
The gels were silver stained by the method of Tsai and Frasch (1982).
3.12.2 Silver Staining. Slab gels were stained using the method of Tsai and Frasch
(1982). Powder-free gloves were used throughout the silver staining procedure. All steps were
performed at room temperature. Gels were transferred from gel cassettes into staining trays filled
with fixative (40% ethanol (ETOH), 5% acetic acid, and 55% deionized water) and placed on a
shaker overnight. After the overnight fixing step, the fixative was discarded and a freshly
prepared oxidizer solution (0.7g oxidizer, 100ml of fixative) was added. The gels were placed on
the shaker for 5 minutes. The gels were washed in deionized water for 15 minutes. This step was
repeated twice. The gels were incubated for 30 minutes in a silver stain (Appendix F) prepared
fresh and followed by three 10 minute washes and developed in a solution containing citric acid
(50mg), 37% formaldehyde (0.5ml) and 1 liter DH2O, and stored in 5% acetic acid.
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3.13 Detection of Prostaglandin E2α
Prostaglandin supernatant of control (PBS) and treated whole blood was evaluated using
commercial Enzyme-linked immunosorbent assay (Cayman) following manufacturer’s
instructions. (See appendix for standard and buffer preparations).
One Hundred (100) μl of EIA Buffer was added to NSB wells, fifty (50) μl of EIA Buffer
was also added to the B0 wells. This was followed by the addition of Prostaglandin E2 EIA
Standards to wells. Fifty (50) μl from tube #8 was added to both of the lowest standard wells
(S8). Fifty (50) μl from tube #7 was also added to each of the next two standard wells (S7). The
procedure was continued until all the standards were aliquoted. The same pipette tip was used to
aliquot all the standards. This was followed by adding fifty (50) μl of plasma sample for each
treatment into each well in triplicates. Fifty (50) μl of AChE Tracer was added to each well
except the TA and the Blk wells. Fifty (50) μl Prostaglandin E2α Monoclonal Antibody was
added to each well except the TA, the NSB, and the Blk wells. The plate was covered with a
plastic film and incubated over night at 4°C. The plate was developed by empting and rinsing
five times with Wash Buffer. Two hundred (200) μl of Ellman’s Reagent was added to each well.
Five (5) μl of tracer was added to the TA well. The plate was covered with plastic film and
placed on an orbital shaker equipped with a large, flat cover for 90 minutes to develop in the
dark. The plate was read by wiping with a clean tissue to remove fingerprints, dirt, etc. The plate
cover was removed and inserted into a micro plate reader (BioTek) and read at wavelengths 405,
410, 415, 417 and 420 nm. SAS was used to plot %B/B0 for standards S1-S8 versus PGE2α
concentration using a logit transformation.
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3.14 Isolation of RNA from Goat peripheral Blood
Total RNA was extracted from blood collected in PaxGene RNA collection tubes
(QIAGEN Inc, Valencia, CA) using the ZR whole-blood Total RNA kit (Zymo Research,
Orange, CA), as recommended by the manufacturer. Briefly, tubes were centrifuged at 3600 rpm
for 15 minutes at 40C. The supernatant was removed and 5 ml of dietylpyrocarbonate (DEPC)
treated water was added, vortexed and centrifuged for 10 minutes. The supernatant was removed
and 3 ml of blood RNA buffer was added and incubated for 10 minutes on ice. Six hundred (600)
µl of the mixture was transferred into a column with a collection tube and centrifuged at 14,000
rpm for 2 minutes. The supernatant was transferred to a fresh column and 400 µl of RNA was
buffer was added to the column and centrifuged at 12,000 rpm for 30 seconds, then transferred
into an RNAase free tube. One hundred (100) µl of RNA recovery buffer was then added to the
column and centrifuged at 12,000 rpm for 30 seconds. One hundred (100) µl of ethanol was then
added to the column with a collection tube and centrifuged at 12,000 rpm for 30 seconds. Four
hundred (400) µl of RNA prep buffer was then added to the column and centrifuged at 12,000
rpm for 1 minute. The flow through was discarded. Eight hundred (800) µl of RNA wash buffer
was then added to the column and centrifuged at 13,000 rpm for 30 seconds. The flow through
was discarded. This step was repeated twice. The column was then transferred into an RNase
free tube. 10 µl of DNase free water was then added to the column and centrifuged at 10,000 rpm
for 30 seconds. This step was repeated again and elute was incubated at 650C for 5 minutes
which was now stored at 200C.
3.15 Neutrophil Isolation
Neutrophil were isolated from whole blood using the modified Carlson and Kaneko
method (Carlson and Kineko, 1973). Briefly, whole Blood from each goat was placed into a 50

32
ml polypropylene conical tube, mixed, balanced and placed on ice. The blood was centrifuged on
a swinging bucket rotor (Eppendorf Centrifuge 5810 R) at 3500 rpm (1800 g) at 40C for 20
minutes. Centrifugation leads to the separation of blood components into plasma, buffy coat and
red blood cell (RBC) layer. Using a vacuum, plasma, buffy coat and 1/3 of the RBC layer of
each tube was carefully aspirated. The caps were replaced and gently inverted to re-suspend
neutrophil/red cell layer and immediately 20 ml of ice cold DEPC treated distilled water was
added. Red blood cells were lysed by inverting and rotating the tube for 45 seconds. Ten (10) ml
of 2.7% saline was added to restore isotonicity and the contents were mixed by rotating and
inverting the tube. Cells were kept cold by returning to ice periodically followed by centrifuging
at 2000 RPM (700 g) at 40C for 2 minutes and discarding the supernatant. The cells were
resuspended in 10 ml of ice cold PBS (pH 7.4) to the pellet and then it was gently inverted and
rotated manually. The whole procedure was repeated in other to obtain a clear white pellet. After
the last addition of cold PBS, cells were placed on ice.
3.15.1 Determination of Total Cell Count and Viability of Neutrophils. Viability and
total cell count of isolated neutrophils was determined by using the Trypan blue dye exclusion
method. Isolated neutrophil were mixed with Trypan blue (Sigma-Aldrich cat #T8154) in a ratio
of 1:1. 10 µl of the mixture was then mixed properly and placed on a TC10 TM system counting
slide. The slide was then inserted into the TC10 TM system (Biorad) to count. The number of
cells that had not taken up the dye was counted as live cells and the results were given in % of
live (viable) cells. Total number of cells was also obtained.
3.16 Isolation of Total RNA from Neutrophils
Neutrophils were adjusted to a concentration of 1x107 cells/ml using PBS and resuspended in 1 ml of Tri-reagent (Molecular Research Centre, USA). The recommended protocol

33
was used. Briefly, cells were incubated at room temperature for 5 minutes. Two hundred (200) µl
of chloroform was added to the tubes shaken manually for 15 seconds and incubated at room
temperature for 15 minutes. This was followed by centrifugation at 1200 g (9,000 RPM in
Eppendorf Model 5810R Centrifuge) at 40C for 15 minutes. The aqueous phase containing the
RNA was transferred to a clean tube. To the aqueous phase, 500 µl of isopropanol was added and
incubated at 40C for 90 minutes to precipitate RNA. Samples were then centrifuged at 12,000 g
at 40C for 8 minutes. The supernatant was discarded. The RNA pellet was then washed with 1 ml
of 95% ethanol. Ethanol was decanted and the pellet was allowed to dry for 15 minutes at room
temperature. The dried RNA pellet was dissolved in 30 µl of sterile DEPC-treated water and then
stored at -800C until further use.
3.16.1 RNA Concentration and Purity. The ND-1000 UV/VIS nanodrop (NanoDrop
Technologies) spectrophotometer was used to determine the concentration and purity of isolated
RNA from PaxGene tubes and neutrophils and DNA from fecal samples. RNase free water was
used as a blank. One (1) µl of RNA was dropped on the nanodrop and the concentration and
purity was determined. Optical densities were read at A260/280 for nucleic acid purity.
3.17 Preparation of cDNA from PMN RNA
Complementary DNA (cDNA) was synthesized using a RETRO script Kit (Ambion Inc.,
Austin, TX) by taking 2 µg of total RNA from each sample and adding 2 µl of Oligo (dT)
(Ambion Inc., Austin, TX) ). The final volume was adjusted to 12 µl by the addition of nuclease
free water in a PCR reaction tube. The samples were vortexed, spun and placed into a
thermocycler (MWG Biotech, Martinsried, Germany) then heated for 3 min at 85ºC, removed
and placed on ice. Next, the remaining reverse transcription components were added to each
sample, 2 µl 10X RT buffer, 4 µL dNTP mix, 1 µl RNase Inhibitor and 1 µl reverse transcriptase
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(RT) (Ambion Inc., Austin, TX) totaling 20 µL in volume. The tubes were vortexed, spun down
and placed into the thermocycler for incubation at 44ºC for 1 hr. to activate reverse transcription
followed by incubation at 92ºC for 10 min to stop the action. Finally, the cDNA products were
measured for purity and concentration using the Nanodrop spectrophotometer (Thermo Scientific
Inc., Waltham, MA) as described above and stored at -20ºC.
3.18 Real Time-PCR
The Qiagen Human Toll-like Receptor RT-PCR kit (Qiagen, Valencia, CA) was used to
detect transcription. Ninety-six-well plates containing gene-specific primer sets for 84 relevant
TLR pathway genes, 5 housekeeping genes, and 2 negative controls were used. After performing
thermal cycling (according to the manufacturer's protocol), real-time amplification data were
gathered by using manufacturers supplied software.
3.19 The Livak Method
Gene expression was normalized to internal controls GAPDH (housekeeping genes) to
determine the fold change in gene expression between test and control samples by using the
2−ΔΔCt method (Livak and Schmittgen, 2001). The C(t) for each gene from the different samples
was standardized to the sample GAPDH value [ΔC(t) = gene C(t) − GAPDH C(t)], and this value
was then compared using the ΔΔC(t) method to determine the fold change {fold change =
[2^(−ΔΔCT)]}. The significance value for the fold change in each gene fold change was
calculated as the difference in gene expression between test samples (hot and cold) and control
sample (water). A positive value indicates gene upregulation, and a negative value indicates gene
downregulation.
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3.20 Statistical Analysis
A crossover analysis, repeated measures and ANOVA was performed on all variables
using the statistical analysis software package SAS (Cody and Smith 1997). Variables included
FAMACHA, body weight, body condition, FEC, PCV, differential white blood cell count, DNA
concentration, protein concentration and purity. To examine significance of the treatment
differences, the F value was calculated by comparing the computed F value with the tabular F at
5% level of significance or P<0.05. All treatment differences with computed F values greater
than tabulated F values at 5% of significance were considered significant. Treatment differences
with computed F value smaller or equal to the tabulated F value at 5% level of significance were
considered not significant. A Pierson correlation and coefficient was used to determine
correlation between variables.
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CHAPTER 4

Results and Discussion

4.1 Body Weight
Initial weight of goats used in this experiment had an average weight of >52 kg across all
groups. There was no significant difference between treatments and control (p<0.1045) at the
end of the study. During the last 4 weeks, there was a time effect (p<0.001) and also correlation
between body weight and lymphocyte cell count (r=0.22, p<0.0028). There was no effect of
CorPet mushroom on body weight. The average mean weight for control was 66.1 kg (Fig. 3).
However CorPet treatment did have an effect on body weight gain, over time, it resulted in a
mean weight of 62.7 kg in the treated animals. Results obtained were within the range of a
normal adult female Boer goat (Coffey, 2002). Goats used in this study were 3 weeks after
weaning and an increase in weight was expected across all treatments. Diet and feed were kept
constant during experimental period in other to rule out any source of variation.
Body weight is an important parameter in determining the health status of an animal over
a certain period of time. A decline in weight can be associated with parasitic infection, high
temperatures that stress the animal and also lack of appropriate nutrition. It is expected that
animals keep a relatively consistent body weight during growth. Healthy normal adult female
Boer goats have a body weight that ranges from 55 kg to 90 kg (Coffey, 2002). In general,
animal studies have been previously reported in the literature and these showed that mushroom
enriched diet had no effect on body weight (Handayani et al., 2012). Also a study that was
carried out on the effect of Pleurotus ostreatus on the effect of weight gain by Daneshamand
(2011), showed that supplementation of mushroom or probiotic had no effect on weight gain
during the entire experiment.
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Figure 3. Effect of CorPet on Body Weight (p>0.05)
4.2 Body Condition
CorPet mushroom probiotic had no effect on body. There was no significant difference in
body condition between animals in the control and treatment groups (Fig. 4). The body condition
scores were in the range of 2 to 3 indicating a healthy animal condition (Mendizabel et al., 2011).
CorPet mushroom probiotic had no effect on body condition. Results in this study shows that
body condition scores could be used to identify goats which are anemic. Body condition scores is
one of the tools goat farmers can use to achieve proper management of body reserves and has
proved to be an effective and easy to use method (Mendizabal et al., 2011).
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Figure 4. Effect of CorPet on Body Condition Scores (p>0.05).
4.3 FAMACHA
The FAMACHA scores were similar between control and treatment groups. There was
no significant difference between treatments and control. There was no correlation between eye
scores and PCV. The FAMACHA score results were in the range of red (FAMACHA = 1) to
red-pink (FAMACHA = 2) indicating that anemia was generally not a major problem in the
study population. This is an effective tool for identifying anemic goats (Kaplan et al, 2004).
The FAMACHA© method can be used as a safe and reliable approach to reducing
pressure in goats on the selection for anthelmintics in relation to routine non-selective treatment
for worm control (Kaplan et al., 2004). This tool could also be used to reduce cost and delay the
development of anthelmintic resistance. It can also be used to improve the genetic resistance of
individual herds or flocks (Bath et al., 2001).
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4.4 Packed Cell Volume
There was no significant difference between treated and control animals. Ogbe et al.,
(2009) reported that there was no effect of aqueous mushroom extract of Ganoderma lucidum on
PCV which correlates with the result obtained in this study. However was a time effect for the
first four weeks (p<0.05) and the last four weeks (p<0.002) which may be associated with
infection as the animals were on pasture. On a weekly base the treatment group had a lower PCV
compared to control. The control group had an average PCV of 26% (Fig. %). A normal PCV for
an adult goat ranges from 24 to 48% (Karki, 2008). PCV is an important tool in the diagnosis of
parasitic infection (Vatta et al., 2002). Kaplan et al., (2004) reported a correlation between PCV
and FEC but there was no correlation between FEC and PCV in this study. The level of infection
may have been low and not caused anemic conditions.
The PCV obtained in this study was within the range of a healthy goat. Low PCV may be
indicative of anemia, which is an undesirable condition that points to a compromised health
status of the animal. It is also an
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4.5 Fecal Egg Count
4.5.1 Haemochus. Haemonchus contortus eggs and coccida oocytes were found in fecal
samples. There was no significant difference between control and treatments. An average mean
of 350 epg was obtained across treatments. However there was an observed trend of increase in
H. Contortus egg count in the first 3 weeks compared to a decrease in the last 5 weeks with
CorPet treatment (Fig. 6).
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Figure 6. The Effect of CorPet Extracts on Haemochus Eggs Per Gram Feces.
4.5.2 Coccidia. There was no significant difference between treatments and control.
There was an observable trend in the results obtained. At the beginning of the experiment there
was a high oocyst count (Fig. 7). During the switch there was a decrease in oocyst count. There
was no effect of CorPet extracts on coccidian oocyst count. Haemochus egg count and Coccidia
oocyst count started off at a high rate but reduced after the first 4 weeks in treated and control
animals. Cold extract treatment had fewer oocysts than the control in week 2, 3, 4, 5 and 7. Hot
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extract treatment tended to increase; maybe extraction method had an effect.
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Figure 7. The Effect of CorPet mushroom Extracts on Coccidia Oocyst per Gram Feces.
Fecal egg count is a parameter widely used to determine parasitic infection in animals
(Kaplan et al., 2004). Basically a high FEC is associated with an elevated presence of adult
parasites in their productive stage in the hosts’ digestive system (Kaplan et al., 2004). It is a tool
to help a scientist to determine the presence of gastrointestinal nematode parasites and severity of
it. Coccidiosis is one of the most important diseases of goats in the United States because of its
effect on productivity, especially growing kids (Levine, 1985). Prevalence of Eimeria infection
is common and contributes to production losses (Valentine et al., 2007). There are some reports
demonstrating positive effects from feeding fungal myceliated grain to chickens (Willis et al.,
2009) and these researchers have observed its potential to control coccidiosis. In another study,
Ogbe et al. (2009) reported that the wild mushroom (Ganoderma lucidum) used to treat E. tenella
infected broilers resulted in a reduction in the number of E. tenella oocysts shed in the faeces and
led to improved weight gain.
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Mushroom extracts can impact gastrointestinal nematode infections under certain
conditions and therefore may eventually play a significant role in an integrated GIN management
protocol for small ruminants. Bioactive compounds or polysaccharides are known to play vital
roles in enhancing health; they block colonization of the intestine by pathogens, thereby
improving their elimination from the body (Elmusharaf et al., 2006).
4.6 Microbial DNA in Fecal samples
The concentration and purity of the microbial DNA isolated from fecal samples is an
indicator of the impact of diet on the microbial population in the rumen and impacts goat
production and health. Samples from treatment and control groups were analyzed for week 0, 4
and 8. During the first week DNA concentration ranged from 14 to 19 ng/µl compared to the 8th
week, which ranged from 5 to 16 ng/µl (Fig. 8). CorPet treatment reduced fecal DNA
concentration from the observable trend.
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Figure 8. Concentration of Microbial DNA in fecal samples ng/µl for week 0(1), week 4(2) and
week 8(3).
There are other results indicating the effect of mushroom on the microbial flora.
Varshney et al., (2013) reported that when white button mushroom was added to the diet of mice,

43
it changed the composition of the normal flora which resulted in better control of inflammation
and resolution of infection. This may also correlate to the result obtained in this study. Hot
extract treatment tends to decrease microbial shedding.
4.7 White Blood Cell Differential Count
There was no significant difference in the percentages of neutrophils, lymphocytes,
monocytes, basophils and eosinophils (p<0.5222) between treatments and control groups. There
was a strong negative correlation between neutrophils and lymphocytes (r=-0.94, p<0.0001) as
well as neutrophils and monocytes (r=-0.19, p<0.0470). Over time there was a significant
increase in the last four weeks in the eosinophil count (p<0.0001). The higher production of
eosinophils observed suggests a potential role in combating GI nematode infections (Balic et al.,
2006). Over time there was a significant increase of lymphocyte count (p<0.007) and a decrease
in neutrophil count (p<0.001) during the last four weeks (Fig. 9 & 10).
100
90

Lymphocyte in %

80
70
60
control
50

cold

40

hot

30
20
10
0
1

2

3

4

5

6

7

8

Figure 9. Effect of CorPet on Lympocyte Cell Count in Percentage.
The high lymphocyte counts in animals in this study might be attributed to stress and
immune response to the environment which harbors various detectable and undetectable parasitic
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organisms. The normal value for white blood cell differential count in goats are 30-48%
neutrophils, 50-70% lymphocytes, 0-1% basophils, 0-8% monocytes and 1-8% eosinophils
(Khan et al., 2010).
There was no effect of CorPet on differential white blood cell count. Stimulation of
production of White blood cells (WBC) in an immunosuppressed animal model has been
classified as an immunomodulatory effect (Kyakulaga et al., 2013). Some other reports have
shown the positive effects of mushroom extracts on differential white blood cell count.
Kyakulaga et al., (2013), reported that aqueous extracts of Auricularia sp and Pleurotus sp from
Ugandan rain forests increased total and differential WBC counts in cyclophosphamide
immunosuppressed Wistar rats.
50
45

Neutrophil in %

40
35
30
control
25

cold

20

hot

15
10
5
0
1

2

3

4

5

6

7

8

Figure 10. Effect of Corpet on Neutrophil Cell Count in Percentage.
The total white blood cell count is a tool to identify potential immune response to a
parasitic challenge and parasite resistance (Kaplan et al, 2004). White Blood cell differential
count normal value for goats in percentage are 34% neutrophils, 53 % lymphocytes, 1%
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basophils, 5 % monocytes and 5% eosinophils (khan and Line, 2010). Observed differential cell
count on the effect of Corpet treatment is shown in Table 2.
Table 2.
White blood differential cell count in percentage Averages (%) of Treatment Groups.
Week

Neutrophil lymphocytes Eosinophils Basophils Monocytes

0

31

67

1

1

0

4

33

64

1

2

0

8

36

62

1

1

0

A differential white blood cell count is an important tool used to provide clinical
diagnosis, monitoring of disease and blood disorders (Houwen, 2001). This system quantifies
and differentiates white blood cells at one particular time giving insight to infection and if
treatments are working (Houwen, 2001).
4.8 Protein Concentration
There was a significant difference between treatments and control (p<0.0001). Over time
there was an increase plasma protein concentration (p<0.001) for the first four weeks and a
decrease in the last four weeks (p<0.0001). As observed during week 2 to 5, treatment had a high
protein concentration compared to control (Fig 11). There was a positive correlation between
plasma protein concentration and neutrophil cell count (r=0.30, p=0.0013). However, a
significant negative correlation was observed between protein concentration and coccidia (r=0.26, p=0.0073). The reduction in hematological parameters such as changes in plasma protein is
common clinical symptom of gastrointestinal parasitism. Immunomodulation by probiotics may
stimulate increase in plasma proteins (Johnson et al., 2009).
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Figure 11. Effect of CorPet mushroom extracts on plasma protein concentration in ng/µl.
4.9 Plasma Protein Migration Pattern on SDS PAGE Gels
The SDS gel electrophoresis showed high band intensity among treatments. There was
difference between treatment and control for week 0, 4 and 8. Protein bands were all the same
across treatments (Fig. 12). Over time the density of bands observed increases and may be an
indicator of the observed effect of CV on plasma protein concentration. Thus CV did not have
adverse effect on cell proteins and white blood cell count.
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Figure 12. SDS Gel Electrophoresis. PM=marker, C1=control week 1, CO1=cold week1, H1=
hot week 1, C4 control week 4, CO4=cold week 4, H4=hot week 4, C8=control week 8, CO8=
cold week 8 and H=hot week 8.
4.10 Secretion of Proinflammatory Cytokines in Plasma
The release of proinflammatory cytokines is essential for host survival from infection,
and is also required for the repair of tissue injury. Proinflammatory cytokine levels were
measured in plasma from the treatment and control groups at week 0, 4 and 8 of the study.
Comparing the production of Eight (8) proinflammatory cytokines, the CV extract induced
detectable levels four (4) cytokines. TNF-α, IL-1a and IL-8 were not detected, IFNr, Rantes and
GCSF increased while GM-CSF levels decreased from weeks 0 to 8. Lim (2011) reported that
antiinflammatory response upon treatment with CV extract correlated with the reduced
expression of TNF-α, IL-1β and IL-6 which corresponds to the low secretion of TNF-α obtained
in this study. Yu et al (2009) also reported a decrease in levels of serum mucosal interleukin-2
(IL-2) and TNF-α in rat with oral ulceration of Lentinus edodes. Also Johnson et al., (2009)
reported that In vivo study of Agaricus blazei reduced the levels of TNF-α by 84% and IL-2 by
46%. Batbayar et al., (2011) reported that β-glucan of Ganoderma lucidum induced the sereetion
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of granulocyte colony-stimulating factor and regulated on activation, normal T expressed and
secreted (RANTES) which correlates with results obtained in this study.
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Figure 13. Effect of CorPet on the Secretion of Cytokines.
The immunomodulatory effects of mushroom are usually associated with the stimulation
of the immune system by a variety of polysaccharides (Jedinak et al., 2011). β-glucan activates
B-lymphocytes and macrophages through Toll-like receptors, modulating the immune system
and inducing the production of cytokines (Liao et al., 2004). The antioxidant activity of Coriolus
versicolor and the limited adsorption of its PSP and PSK across the intestinal mucosa to the
blood have been reported. However in this study treatment with CV extracts by drenching
stimulated cytokine secretion in different manner over time. GCSF and GMCSF may be
associated with the release of granulocytes and mononuclear cells and associated with the
observed increases in white blood differential counts for neutrophils and lymphocytes.
Coriolus versicolor has been reported to improve survival and immune function (in vivo)
(Amberg et al., 2010). Infections with Eimeria have been observed to result in differential
cytokine gene expression of IL-10 (Rothwell et al., 2004) and IL-8 in cattle (Coussens, 2004). In
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this present study these cytokines were not secreted. Chang et al., (2009) reported that oral
administration of Enoki mushroom displayed anti-tumor activity through activating both innate
and adaptive immunity of the host to prime a cytotoxic immune response and IFN-γ played a key
role in the anti-tumor efficacy. Seong et al., (2010) reported that when cells were stimulated with
β-glucan the macrophage cells increased TNF-α expression, but in our study there was no
secretion of TNF-α.
4.11 Secretion of Prostaglandin E2α
PGE2α is an inflammatory mediator that secreted by various cells. In this study, over time
there was a decrease of PGE2α secretion from week 1 to week 8. Results in this study correlates
with the study done by Jedinak et al., (2011) which reported that concentrate of oyster mushroom
inhibited production of prostaglandin E2 through the down regulation of expression of COX-2.
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Figure 14. Effect of CorPet on the secretion of PGE2α.
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4.12 RNA Concentration
There was no statistical significance between treatment and control (p<0.42). There was
an observable trend of a decrease in RNA concentration in samples from treated goats compared
to controls for the first 3 weeks and an increase in weeks 4 to 7 (Fig. 15). There was a time effect
(p<0.001). Treatment increased RNA concentration in weeks 4 to 6.
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Figure 15. Effect of CorPet on RNA Concentration from whole Blood in PaXgene Tubes.
4.13 Effect of CorPet on Gene Expression
Innate immunity can be stimulated by the activation of pattern recognition receptors. At
the beginning of the study the number of neutrophil genes detected in the Human Toll-like
Receptor RT-PCR (Qiagen, Valencia, CA) array was similar for animals in the treatment groups
(Table 3) (See gene list Appendix). Data was analyzed by subtracting the C(t) value from
GAPDH. Also data was analyzed by using the C(t) values for each group as a control week 1.
After 8 weeks, there was an effect of treatment on the regulation of genes. Thirty-seven (37)
genes were up regulated and forty-seven (47) genes were down regulated for the hot treatment.
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Twenty-eight (28) genes were up regulated, fifty-six (56) genes were unchanged for the cold
treatment.
Table 3.
Number of Genes Expressed after 8 weeks.
Control

Hot

Cold

Higher

38

26

21

Equal

20

11

10

Lower

26

47

53

These genes function as receptors, in signaling, adaptors and effectors of the toll-like
receptor pathway. TAB1 and TIRAP (Appendix) had the highest fold change. At week 1 all Tolllike receptors except TLR3 and TLR7 were expressed. At week 8 TLR2 was unchanged and
TLR7 was upregulated. Neutrophils express the majority of TLR family members, lacking only
the intracellular receptors TLR3 and TLR7 (Prince et al., 2011) which correlates with the result
obtained from this study. Ten Toll like receptors have been identified in goats and expression
has been reported in different tissue (Tirumurugaan et al., 2010), however there are no reports in
goat neutrophils. Bovine neutrophil have been reported to express TLR (Worku et al., 2009). The
TLR1 family (TLR1, 2, 6 and 10) is involved in the recognition of gram-positive and gramnegative bacteria and heterodimers of TLR1 or TLR6 with TLR2 are crucial for the identification
of several PAMPs (Kwong et al., 2011). TLRs recognize conserved pathogen-associated
molecular patterns that are unique to microorganisms and are absent from higher eukaryotes
(Han et al., 2003). Batbayar et al., (2011) reported that expression of TLR2, TLR4 and TLR6
was increased by β-glucan from Ganoderma lucidum. TLR2 signaling and TLR4 signaling

52
additionally require the bridging adapter Toll-interleukin- 1 receptor (TIR) domain containing
adapter protein (TIRAP)/MyD88-adapter like (Mal) to link the receptors (Prince et al., 2011).
The critical role of TIRAP in host defense against Escherichia coli has been reported (Jeyaseelan
et al., 2005). This result correlates with our study.
Gene expression was analyzed for week 0 and week 8 (Table 4) was analyzed using the
Livak method to determine the effect of treatment.
Table 4
Gene Expression for first week and week 8
Week 1

Week 8

Hot

Cold

Hot

Cold

Up regulated

54

13

75

40

Unchanged

26

56

8

44

Down regulated

4

15

0

0

There was an increase in fold change for the hot treatment group for IL2, IL6, IL8,
ECSIT, TAB1, TLR10 and TLR4 (Fig. 16). Mushroom supplementation increased intracellular
interleukin (IL)-6 levels suggesting an enhancement of both innate and T cell-mediated
immunity which leads to a more efficient surveillance and defense mechanism against microbial
invasion (Ren et al., 2008b).
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Figure 16. Expression change for a selected set of genes across all of the tested groups for week
1.Group1=Hot treatment, Group 2=Cold Treatment.
There was a decrease in fold change for CCL2 and TNF in the hot treatment. For the cold
treatment group there was an increase in fold change for CCL2, IL8, TAB1, ECSIT, TLR4 and a
decrease in IL2, IL6, TLR10 and TNF (Fig. 17).

Figure 17. Expression change for a selected set of genes across all of the tested groups for week
1. Group1=Hot treatment, Group 2=Cold Treatment.
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The decrease in fold change for TNF could correlate with the lack of secretion of TNF in
the detection of cytokines. The fold change for TLR4, IL8, TAB1 and ECSIT was increased in
both the hot and cold treatments. It has being reported that components of Coriolus versicolor
stimulate T cell activation, induce IFN-γ and IL-2 production, reduce gene expression of
cytokines (TNF-α, IL-1, IL-6, IL-8) (Cui et al., 2003) which is concordance with the lack of
secretion of TNF-, IL-1a and IP-10 in plasma. Response to bacterial- and fungal-specific cell
wall components through these receptors can be responsible for the initiation of not only the
inflammatory response but also may direct the adaptive response through activation of specific T
cells such as Th1, Th2 and T regulatory cell subsets (Price et al., 2010).
Thus in our study on goat neutrophils the administration of a probiotic containing CV
modulated toll like receptors and molecules involved in downstream signaling. In light of the
critical role of TLR in controlling bacterial infections the expression and modulation of these
genes may be critical to goat health and modulation of innate immunity using mushroom based
probiotics. The expression of 8 TLRs in goat neutrophils has implications to innate immunity in
goat and efforts to modulate it through novel therapeutics.
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10 CHAPTER 5
Conclusion and Future Research
Mushrooms and mushroom components have been reported to have a myriad of positive
health benefits, mainly on the basis of in vitro and in vivo animal trials (Roupas et al., 2012).
Although there has been relatively few direct intervention trials of mushroom consumption in
animals, those that have been completed to date indicate that mushrooms and their extracts are
generally well-tolerated. The results of this study show that mushroom extracts of Coriolus
versicolor did not reduce gastrointestinal parasites in goats. The probiotics extracts of CV did not
have an adverse effect on goat health and production. CV Extracts had an impact on protein
concentration, cytokine levels and RNA. CV probiotics had an impact on gene expression
targeting the toll-like pathway associated with innate immunity.
This study has identified gene and proteins that are responsive to mushroom
supplementation and may serve as targets for future interventions to enhance goat immunity.
Further studies using more samples are needed to assess the impact on microbial diversity, feed
efficiency and on global gene expression.
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Appendix A
Reagents
1. Acid Citrate Dextrose
For 500 ml
22 g Trisodium citrate (Amhydrous)
8 g Citric acid
25 g Dextrose
Bring up to 500 mls with sterile water
Autoclave and store at 40C
2. DEPC-Treated Water
1 ml of DEPC was added to 1 liter of distilled water, mixed vigorously and let stand
overnight
Then autoclave
3. 2.7% Saline
27 g NaCl
Bring volume up to 1 liter with DEPC
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PCR Components Mix
2X RT2 SYBR Green Mastermix

1350 µl

cDNA

102 µl

RNase-free water

1248 µl

Total volume

2700 µl

PCR Thermal Cycling conditions
Cycles

Duration

Temperature

1

10 minutes

950C

40

15 seconds

950C

1 minute

600C
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Appendix B
15 Source: Pierce BCA Handbook
Preparation of Diluted Albumin (BSA) Standards
Dilution Scheme for Standard Test Tube Protocol and Microplate Procedure (Working
Range = 20–2,000 µg/ml)
Vial

Volume of Diluent

Volume and Source of BSA

Final BSA Concentration

A

0

300 µl of Stock

2,000 µg/ml

B

125 µl

375 µl of Stock

1,500 µg/ml

C

325 µl

325 µl of Stock

1,000 µg/ml

D

175 µl

175 µl of vial B dilution

750 µg/ml

E

325 µl

325 µl of vial C dilution

500 µg/ml

F

325 µl

325 µl of vial E dilution

250 µg/ml

G

325 µl

325 µl of vial F dilution

125 µg/ml

H

400 µl

100 µl of vial G dilution

25 µg/ml

I

400 µl

0

0 µg/ml = Blank
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Appendix C
16 Source: Signosis Human Inflammation ELISA Strip Protein Standards Handbook
Reagent Preparation
Dilute the 5x Assay wash buffer to 1x buffer
40ml 5x Assay wash buffer
160ml ddH2O
Use serum-free conditioned media or original or 10-fold diluted sera.
Sera can be diluted with 1X
Diluent buffer. When serum-containing conditioned media is required, be sure to use serum as a
control.
Dilute 50 times of biotin labeled antibody mixture with 1X Diluent buffer.
Dilute 200 times of streptavidin-HRP with 1X Diluent buffer.
Assay procedure
1. Cut the sealing film over the plate and remove it from the desired number of well strips. Make
sure the rest of wells are well sealed.
2. Add 100 µl of Standard, control, or sample per well and incubate for 1 hour at room
temperature with gentle shaking.
3. Aspirate each well and wash by adding 200µl of 1X Assay wash buffer. Repeat the process
three times for a total of three washes. Complete removal of liquid at each wash. After the last
wash, remove any remaining liquid by inverting the plate against clean paper towels.
4. Add 100µl of diluted biotin-labeled antibody mixture to each well and incubate for 1 hour at
room temperature with gentle shaking.
5. Repeat the aspiration/wash as in step 3.
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6. Add 100 µl of diluted streptavidin-HRP conjugate to each well and incubate for 45 min at
room temperature with gentle shaking.
7. Repeat the aspiration/wash as in step 3.
8. Add 100µl substrate to each well and incubate for 10- 30 minutes.
9. Add 50µl of Stop solution to each well. The color in the wells should change from blue to
yellow.
10. Determine the optical density of each well with a microplate reader at 450 nm within 30
minutes.
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Appendix D
17 Source: Bio-Rad, DCode Universal Detection System Handbook
Tsai and Frasch Silver Stain
Materials and Equipment needed:
•

Orbital Shaker

•

Staining tray

•

Ethanol Acetic Acid

•

Periodic acid

•

Silver nitrate NaOH

•

Citric acid

•

Formaldehyde

•

DH2O

1. Use Powder-free gloves throughout the silver staining procedure.
2. Transfer gels from gel cassettes into staining trays filled with fixative (1).
3. Place on a shaker overnight to fix the samples. Perform all steps at room temperature.
4. After the overnight fixing step, discard the fixative and add the oxidizer solution (2). Make
fresh daily. Place the gel on the shaker for 5 minutes.
5. Wash the gel in DH2O for 15 minutes. Repeat this step twice.
6. Incubate the gel 30 minutes in silver stain solution (3). Prepare fresh and follow with three 10
minute washes.
7. Develop the gel in developer solution.
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Solutions
1) Fixative
Ethanol

400 ml

Acetic acid

50 ml

DH2O

550 ml

2) Oxidizer (Prepare fresh daily)
Solution (1)

100 ml

Periodic acid

0.7 g

3) Silver Stain (Prepare fresh daily)
DH 2 O

115 ml

NaOH

(0.4 g/ 100ml DH 2O) 28.0 ml

*AgNO3

(1 g/5ml) 5.0 ml

*Conc NH4OH

2.0 ml

*Add last and simultaneously
4) Developer
Citric acid

50 mg

37% Formaldehyde

0.5 ml

DH2O

1 liter

5) Stop Solution (10% Acetic acid)
Acidic acid

100 ml

DH2O

900 ml
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Appendix E
18 Source: Qiagen Human Toll-like Receptor pathway handbook
Symbol
BTK
CASP8
CCL2
CD14
CD80
CD86
CHUK
CLEC4E
CSF2
CSF3
CXCL10
EIF2AK2
ELK1
FADD
FOS
HMGB1
HRAS
HSPA1A
HSPD1
IFNA1
IFNB1
IFNG
IKBKB
IL10
IL12A
IL1A
IL1B
IL2
IL6
IL8
IRAK1
IRAK2
IRF1
IRF3
JUN
LTA
CD180

Description
Bruton agammaglobulinemia tyrosine kinase
Caspase 8, apoptosis-related cysteine peptidase
Chemokine (C-C motif) ligand 2
CD14 molecule
CD80 molecule
CD86 molecule
Conserved helix-loop-helix ubiquitous kinase
C-type lectin domain family 4, member E
Colony stimulating factor 2 (granulocyte-macrophage)
Colony stimulating factor 3 (granulocyte)
Chemokine (C-X-C motif) ligand 10
Eukaryotic translation initiation factor 2-alpha kinase 2
ELK1, member of ETS oncogene family
Fas (TNFRSF6)-associated via death domain
FBJ murine osteosarcoma viral oncogene homolog
High mobility group box 1
V-Ha-ras Harvey rat sarcoma viral oncogene homolog
Heat shock 70kDa protein 1A
Heat shock 60kDa protein 1 (chaperonin)
Interferon, alpha 1
Interferon, beta 1, fibroblast
Interferon, gamma
Inhibitor of kappa light polypeptide gene enhancer
in B-cells, kinase beta
Interleukin 10
Interleukin 12A (natural killer cell stimulatory
factor 1, cytotoxic lymphocyte maturation factor 1, p35)
Interleukin 1, alpha
Interleukin 1, beta
Interleukin 2
Interleukin 6 (interferon, beta 2)
Interleukin 8
Interleukin-1 receptor-associated kinase 1
Interleukin-1 receptor-associated kinase 2
Interferon regulatory factor 1
Interferon regulatory factor 3
Jun proto-oncogene
Lymphotoxin alpha (TNF superfamily, member 1)
CD180 molecule
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LY86
LY96
MAP2K3
MAP2K4
MAP3K1
MAP3K7
TAB1
MAP4K4
MAPK8
MAPK8IP3

Lymphocyte antigen 86
Lymphocyte antigen 96
Mitogen-activated protein kinase kinase 3
Mitogen-activated protein kinase kinase 4
Mitogen-activated protein kinase kinase kinase 1
Mitogen-activated protein kinase kinase kinase 7
TGF-beta activated kinase 1/MAP3K7 binding protein 1
Mitogen-activated protein kinase kinase kinase kinase 4
Mitogen-activated protein kinase 8
Mitogen-activated protein kinase 8 interacting protein 3
Myeloid differentiation primary response gene (88)

MYD88
NFKB1
NFKB2
NFKBIA
NFKBIL1
NFRKB
NR2C2
PELI1
PPARA
PRKRA
PTGS2
REL
RELA
RIPK2
SARM1
SIGIRR
ECSIT
TBK1
TICAM2
TIRAP
TLR1
TLR10
TLR2
TLR3
TLR4
TLR5

Nuclear factor of kappa light polypeptide gene
enhancer in B-cells 1
Nuclear factor of kappa light polypeptide gene
enhancer in B-cells 2 (p49/p100)
Nuclear factor of kappa light polypeptide gene
enhancer in B-cells inhibitor, alpha
Nuclear factor of kappa light polypeptide gene
enhancer in B-cells inhibitor-like 1
Nuclear factor related to kappaB binding protein
Nuclear receptor subfamily 2, group C, member 2
Pellino homolog 1 (Drosophila)
Peroxisome proliferator-activated receptor alpha
Protein kinase, interferon-inducible double
stranded RNA dependent activator
Prostaglandin-endoperoxide synthase 2
(prostaglandin G/H synthase and cyclooxygenase)
V-rel reticuloendotheliosis viral oncogene homolog (avian)
V-rel reticuloendotheliosis viral oncogene
homolog A (avian)
Receptor-interacting serine-threonine kinase 2
Sterile alpha and TIR motif containing 1
Single immunoglobulin and toll-interleukin 1
receptor (TIR) domain
ECSIT homolog (Drosophila)
TANK-binding kinase 1
Toll-like receptor adaptor molecule 2
Toll-interleukin 1 receptor (TIR) domain containing
adaptor protein
Toll-like receptor 1
Toll-like receptor 10
Toll-like receptor 2
Toll-like receptor 3
Toll-like receptor 4
Toll-like receptor 5
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TLR6
TLR7
TLR8
TLR9
TNF
TNFRSF1A
TOLLIP
TRAF6
TICAM1
UBE2N
UBE2V1
B2M
HPRT1
RPL13A
GAPDH
ACTB
HGDC
RTC
RTC
RTC
PPC
PPC
PPC

Toll-like receptor 6
Toll-like receptor 7
Toll-like receptor 8
Toll-like receptor 9
Tumor necrosis factor
Tumor necrosis factor receptor superfamily, member 1A
Toll interacting protein
TNF receptor-associated factor 6
Toll-like receptor adaptor molecule 1
Ubiquitin-conjugating enzyme E2N
Ubiquitin-conjugating enzyme E2 variant 1
Beta-2-microglobulin
Hypoxanthine phosphoribosyltransferase 1
Ribosomal protein L13a
Glyceraldehyde-3-phosphate dehydrogenase
Actin, beta
Human Genomic DNA Contamination
Reverse Transcription Control
Reverse Transcription Control
Reverse Transcription Control
Positive PCR Control
Positive PCR Control
Positive PCR Control
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Appendix F
The scatter plot compares the normalized expression of every gene on the array between two
groups by plotting them against one another to quickly visualize large gene expression changes.
The central line indicates unchanged gene expression.

Figure 18. Scatter plot showing number of up regulated genes (red), down regulated genes
(green) and unchanged genes (black) for hot treatment week 0.
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Figure 19. Scatter plot showing number of up regulated genes (red), down regulated genes
(green) and unchanged genes (black) for cold treatment week 0.
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Figure 20. Scatter plot showing number of up regulated genes (red), down regulated genes
(green) and unchanged genes (black) for hot treatment week 8.

.

Figure 16. Scatter plot showing number of up regulated genes (red), down regulated
genes (green) and unchanged genes (black) for cold treatment week 8.

84
Appendix G
Table 3.
Summary of Effect of Treatments
Hot

Cold

FAMACHA

-

-

Body Weight

-

-

Body Condition

-

-

Fecal Egg Count

-

-

PCV

-

-

White Blood Cell Differential

-

-

RNA Concentration

-

-

Plasma Protein Concentration

+

+

Cytokines

+

+

Up Regulation

75

40

Down Regulation

8

44

Unchanged

0

0

Gene Regulation

-no effect, + effect
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Appendix H
19 Source: Cayman ELISA Handbook
Addition of EIA Buffer to wells
One Hundred (100) μl of EIA Buffer was added to NSB wells. Fifty (50) μl of EIA
Buffer was also added to the B0 wells
Addition of Prostaglandin E2 EIA Standards to wells
Fifty (50) μl from tube #8 was added to both of the lowest standard wells (S8). Fifty (50)
μl from tube #7 was also added to each of the next two standard wells (S7). The procedure was
continued until all the standards were aliquoted. The same pipette tip should was used to aliquot
all the standards
Addition of Samples to wells
Fifty (50) μl of sample was added per well. Each sample should be assayed was assayed
in triplicates
Addition of Prostaglandin E2 AChE Tracer
Fifty (50) μl of AChE Tracer was added to each well except the TA and the Blk wells.
Addition of Prostaglandin E2 Monoclonal Antibody
Fifty (50) μl was added to each well except the TA, the NSB, and the Blk wells
Incubation of plate
The plate was covered with a plastic film and incubated over night at 4°C.
Development of the Plate
Wells were emptied and rinsed five times with Wash Buffer. Two hundred (200) μl of
Ellman’s Reagent was added to each well. Five (5) μl of tracer was added to the TA well. The
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plate was covered with plastic film and placed on an orbital shaker equipped with a large, flat
cover for 90 minutes to develop in the dark.
Reading the Plate
The bottom of the plate was wiped with a clean tissue to remove fingerprints, dirt, etc.
The plate cover was removed. The plate was inserted into a micro plate reader (BioTek) read at
wavelengths 405, 410, 415, 417 and 420 nm.
Standard Curve
SAS was used to plot %B/B0 for standards S1-S8 versus PGE2 concentration using a
logit transformation.

